SRS Compared with FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

Recruiting

Phase 2

SRS Compared with FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE TrialSRS Compared with FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

Sponsor:

Mayo Clinic

Code:

NCT05222620

Conditions

Metastatic Malignant Neoplasm in the Brain

Metastatic Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Questionnaire Administration

Stereotactic Radiosurgery

Magnetic Resonance Imaging

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2025-03-25.